Deichen J T, Schmidt C, Prante O, Maschauer S, Papadopoulos T, Kuwert T
Nuklearmedizinische Klinik, Friedrich-Alexander-Universität Erlangen-Nürnberg, Krankenhausstrasse 12, 91054 Erlangen, Germany.
Eur J Nucl Med Mol Imaging. 2004 Apr;31(4):507-12. doi: 10.1007/s00259-003-1401-0. Epub 2004 Jan 14.
Recent clinical evidence suggests that positron emission tomography with fluorine-18 fluorodeoxyglucose (FDG-PET) is more accurate in detecting thyroid carcinomatous tissue at high than at low TSH levels. The aim of this study was to determine the influence of TSH on FDG uptake in human thyroid cells in vitro. Monolayers of human thyroid tissue were cultured after mechanical disintegration and enzymatic digestion of samples from patients undergoing surgery for nodular goitre. The purity of thyroid cell preparations was ascertained by immunohistochemical staining for the epithelial antigen KL-1, and their viability by measuring the synthesis of thyroglobulin in vitro. The cells were incubated with 0.8-1.5 MBq FDG/ml uptake medium for 1 h. FDG uptake in thyroid cells was quantified as percent of whole FDG activity per well (% ID) or as % ID in relation to total protein mass. This experimental protocol was subsequently varied to study the effect of incubation time, glucose dependency and TSH. Furthermore, radio-thin layer chromatography was used to identify intracellular FDG metabolites. FDG accumulated in the thyroid cells linearly with time, doubling roughly every 20 min. Uptake was competitively inhibited by unlabelled glucose and decreased to approximately 70% at 100 mg/dl glucose compared to the value measured in glucose-free medium. FDG was intracellularly trapped as FDG-6 phosphate and FDG-1,6-diphosphate. TSH significantly increased FDG uptake in vitro in a time- and concentration-dependent manner: Cells cultured at a TSH concentration of 50 micro U/ ml doubled FDG uptake compared to TSH-free conditions, and uptake after 72 h of TSH pre-incubation was approximately 300% of that without TSH pre-incubation. TSH stimulates FDG uptake by benign thyroid cells in a time- and concentration-dependent manner. This supports the clinical evidence that in well-differentiated thyroid carcinomas, most of which are still TSH-sensitive, FDG-PET is more accurate at high levels of TSH.
近期临床证据表明,使用氟 - 18氟脱氧葡萄糖的正电子发射断层扫描(FDG - PET)在高促甲状腺激素(TSH)水平时比在低TSH水平时更准确地检测甲状腺癌组织。本研究的目的是确定TSH对体外培养的人甲状腺细胞中FDG摄取的影响。对接受结节性甲状腺肿手术患者的样本进行机械破碎和酶消化后,培养人甲状腺组织单层细胞。通过上皮抗原KL - 1的免疫组织化学染色确定甲状腺细胞制剂的纯度,并通过体外测量甲状腺球蛋白的合成确定其活力。将细胞与0.8 - 1.5 MBq FDG/毫升摄取培养基孵育1小时。甲状腺细胞中的FDG摄取量以每孔全FDG活性的百分比(% ID)或相对于总蛋白质量的% ID进行定量。随后改变该实验方案以研究孵育时间、葡萄糖依赖性和TSH的影响。此外,使用放射性薄层色谱法鉴定细胞内FDG代谢物。FDG在甲状腺细胞中随时间呈线性积累,大约每20分钟翻倍。未标记的葡萄糖竞争性抑制摄取,与在无葡萄糖培养基中测得的值相比,在100 mg/dl葡萄糖时摄取量降至约70%。FDG作为FDG - 6 - 磷酸和FDG - 1,6 - 二磷酸被细胞内捕获。TSH以时间和浓度依赖性方式显著增加体外FDG摄取:与无TSH条件相比,在50微单位/毫升TSH浓度下培养的细胞使FDG摄取量翻倍,并且TSH预孵育72小时后的摄取量约为未进行TSH预孵育时的300%。TSH以时间和浓度依赖性方式刺激良性甲状腺细胞摄取FDG。这支持了临床证据,即在大多数仍对TSH敏感的分化良好的甲状腺癌中,FDG - PET在高TSH水平时更准确。